Your browser doesn't support javascript.
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives.
Sampath, Vanitha; Rabinowitz, Grace; Shah, Mihir; Jain, Surabhi; Diamant, Zuzana; Jesenak, Milos; Rabin, Ronald; Vieths, Stefan; Agache, Ioana; Akdis, Mübeccel; Barber, Domingo; Breiteneder, Heimo; Chinthrajah, Sharon; Chivato, Tomas; Collins, William; Eiwegger, Thomas; Fast, Katharine; Fokkens, Wytske; O'Hehir, Robyn E; Ollert, Markus; O'Mahony, Liam; Palomares, Oscar; Pfaar, Oliver; Riggioni, Carmen; Shamji, Mohamed H; Sokolowska, Milena; Jose Torres, Maria; Traidl-Hoffmann, Claudia; van Zelm, Menno; Wang, De Yun; Zhang, Luo; Akdis, Cezmi A; Nadeau, Kari C.
  • Sampath V; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, USA.
  • Rabinowitz G; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, USA.
  • Shah M; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, USA.
  • Jain S; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, USA.
  • Diamant Z; Departmentt of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.
  • Jesenak M; Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
  • Rabin R; Department of Clinical Pharmacy &Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Vieths S; Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
  • Agache I; Department of Pediatrics and Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine in Martin, Center for Vaccination in Special Situations, University Hospital in Martin, Comenius University in Bratislava, Bratislava, Slovakia.
  • Akdis M; Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Barber D; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
  • Breiteneder H; Transylvania University, Brasov, Romania.
  • Chinthrajah S; Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Zurich, Switzerland.
  • Chivato T; Departamento de CienciasMédicasBásicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
  • Collins W; Instituto de Salud Carlos III, RETIC ARADYAL, Madrid, Spain.
  • Eiwegger T; Division of Medical Biotechnology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Fast K; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, USA.
  • Fokkens W; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, USA.
  • O'Hehir RE; School of Medicine, University CEU San Pablo, Madrid, Spain.
  • Ollert M; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, USA.
  • O'Mahony L; Department of Medicine, Division of Hospital Medicine, Stanford University, Stanford, CA, USA.
  • Palomares O; Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Hospital for Sick Children, Toronto, ON, Canada.
  • Pfaar O; Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
  • Riggioni C; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Shamji MH; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, USA.
  • Sokolowska M; Department of Otorhinolaryngology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Jose Torres M; Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University, and Alfred Health, Melbourne, Vic, Australia.
  • Traidl-Hoffmann C; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • van Zelm M; Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • Wang Y; Department of Medicine and School of Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.
  • Zhang L; Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain.
  • Akdis CA; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Nadeau KC; Department of Paediatrics, Allergy and Clinical Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Allergy ; 76(6): 1640-1660, 2021 06.
Article in English | MEDLINE | ID: covidwho-1165739
ABSTRACT
Vaccines are essential public health tools with a favorable safety profile and prophylactic effectiveness that have historically played significant roles in reducing infectious disease burden in populations, when the majority of individuals are vaccinated. The COVID-19 vaccines are expected to have similar positive impacts on health across the globe. While serious allergic reactions to vaccines are rare, their underlying mechanisms and implications for clinical management should be considered to provide individuals with the safest care possible. In this review, we provide an overview of different types of allergic adverse reactions that can potentially occur after vaccination and individual vaccine components capable of causing the allergic adverse reactions. We present the incidence of allergic adverse reactions during clinical studies and through post-authorization and post-marketing surveillance and provide plausible causes of these reactions based on potential allergenic components present in several common vaccines. Additionally, we review implications for individual diagnosis and management and vaccine manufacturing overall. Finally, we suggest areas for future research.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 / Hypersensitivity Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Allergy Year: 2021 Document Type: Article Affiliation country: All.14840

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 / Hypersensitivity Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Allergy Year: 2021 Document Type: Article Affiliation country: All.14840